Macquarie Group’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-654
Closed -$20.9K 2285
2022
Q2
$19K Buy
+654
New +$28.6K ﹤0.01% 2332
2019
Q1
Sell
-1,500
Closed -$15K 1980
2018
Q4
$15K Buy
+1,500
New +$20.1K ﹤0.01% 1853
2017
Q3
Sell
-76,122
Closed -$1.73M 2149
2017
Q2
$1.73M Sell
76,122
-18,308
-19% -$376K ﹤0.01% 1011
2017
Q1
$1.84M Sell
94,430
-2,677
-3% -$52K ﹤0.01% 994
2016
Q4
$1.54M Sell
97,107
-2,700
-3% -$44.9K ﹤0.01% 1043
2016
Q3
$2.02M Sell
99,807
-99,893
-50% -$1.83M ﹤0.01% 955
2016
Q2
$3.57M Buy
+199,700
New +$2.97M ﹤0.01% 985

Other funds holding SGRY

Macquarie Group's SGRY Position: Q3 2022 in Review

Macquarie Group sold out of Surgery Partners (SGRY) in Q3 2022, closing a stake of 654 shares — an estimated $20.9K sold.

Macquarie Group first reported a position in SGRY in Q2 2016 and held it in 7 quarters. The position peaked at $3.57M in Q2 2016. 138 funds tracked by Wall St. Rank hold SGRY as of Q3 2022.

  • Macquarie Group reported no remaining Surgery Partners position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 654 Surgery Partners shares in Q3 2022, an estimated $20.9K.
  • Macquarie Group first reported a position in Surgery Partners in Q2 2016 and held it in 7 quarters.
  • Macquarie Group's Surgery Partners position peaked at $3.57M in Q2 2016.
  • 138 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.